PanTher Therapeutics, Inc.

Austin, TX · Founded 2014 · CIK 0001644045 · Medtech · Private

Localized drug delivery system that enables continuous high-dose chemotherapy exclusively at tumor sites

panthertx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$12M
9 Form D · Apr 2025
18 months since last filing
Contracts
—
No federal contracts on record
Patents
12
2 granted · 10 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$95,000
Private capital raisedForm D · SEC$35,000
Private capital raisedForm D · SEC$268,061
Private capital raisedForm D · SEC$209,488
Private capital raisedForm D · SEC$3,032,514
Private capital raisedForm D · SEC$1,061,000
Private capital raisedForm D · SEC$1,261,500
Private capital raisedForm D · SEC$2,676,030
Private capital raisedForm D · SEC$3,021,707
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
747Bay Labs, Inc.——
748Endoscopy Assist Devices LLC——
749NVE CORP. (FORMERLY NONVOLATILE ELECTRONICS, INC.——
750PanTher Therapeutics, Inc.—$12M
751NESHER TECHNOLOGIES INC——
752BACKYARD BRAINS, INC.——
753Greppo Technologies LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 14 related persons
  • Manish BhandariDirector
  • MANISH BHANDARIDirector
  • Elazer EdelmanDirector
  • John EdwardsDirector
  • Laura IndolfiDirector · Executive Officer
  • LAURA INDOLFIDirector · Executive Officer
  • D MackeyDirector
  • Maria PalasisDirector
  • MARIA PALASISDirector
  • David TingDirector
  • DAVID TINGDirector
  • Daniel WildmanDirector
  • Darshana ZaveriDirector
  • DARSHANA ZAVERIDirector

Patents

USPTO · 2 granted of 12
  • Methods Of Treating Pancreatic Cancerapplication
  • Methods Of Treating Pancreatic Cancergranted
  • Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
  • Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofgranted
  • Tissue Penetrating And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
  • Methods Of Treating Pancreatic Cancerapplication
  • Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
  • Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
  • Methods Of Treating Pancreatic Cancerapplication
  • Tissue Penetrating And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
  • Tissue Penetrating And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication
  • Implantable And Biodegradable Drug Delivery Devices And Methods Of Use Thereofapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.